Literature DB >> 19273752

Midlife and late-life obesity and the risk of dementia: cardiovascular health study.

Annette L Fitzpatrick1, Lewis H Kuller, Oscar L Lopez, Paula Diehr, Ellen S O'Meara, W T Longstreth, José A Luchsinger.   

Abstract

BACKGROUND: While high adiposity in middle age appears to be related to greater dementia risk, studies exploring this association in the elderly are conflicting.
OBJECTIVE: To evaluate associations between midlife and late-life obesity and risk of dementia.
DESIGN: Prospective study with mean follow-up of 5.4 years (1992-1994 through 1999).
SETTING: Community-dwelling sample in 4 US sites recruited from Medicare eligibility files. PARTICIPANTS: A total of 2798 adults without dementia (mean age, 74.7 years; 59.1% women) participating in the Cardiovascular Health Study who underwent magnetic resonance imaging were measured for height and weight at baseline at age 65 years or older (late life), and self-reported weight at age 50 years (midlife). Body mass index (BMI) (calculated as weight in kilograms divided by height in meters squared) was calculated at both times. MAIN OUTCOME MEASURES: Dementia, Alzheimer disease, and vascular dementia classified by a multidisciplinary committee using standardized criteria.
RESULTS: Classification resulted in 480 persons with incident dementia, 245 with Alzheimer disease (no vascular dementia), and 213 with vascular dementia (with or without Alzheimer disease). In evaluations of midlife obesity, an increased risk of dementia was found for obese (BMI >30) vs normal-weight (BMI 20-25) persons, adjusted for demographics (hazard ratio [HR], 1.39; 95% confidence interval [CI], 1.03-1.87) and for cardiovascular risk factors (1.36; 0.94-1.95). The risk estimates were reversed in assessments of late-life BMI. Underweight persons (BMI <20) had an increased risk of dementia (1.62; 1.02-2.64), whereas being overweight (BMI >25-30) was not associated (0.92; 0.72-1.18) and being obese reduced the risk of dementia (0.63; 0.44-0.91) compared with those with normal BMI.
CONCLUSION: These results help explain the "obesity paradox" as differences in dementia risk across time are consistent with physical changes in the trajectory toward disability.

Entities:  

Mesh:

Year:  2009        PMID: 19273752      PMCID: PMC3513375          DOI: 10.1001/archneurol.2008.582

Source DB:  PubMed          Journal:  Arch Neurol        ISSN: 0003-9942


  42 in total

1.  Stemming the tide of diabetes mellitus.

Authors:  J Mann
Journal:  Lancet       Date:  2000-10-28       Impact factor: 79.321

2.  Accelerated weight loss may precede diagnosis in Alzheimer disease.

Authors:  David K Johnson; Consuelo H Wilkins; John C Morris
Journal:  Arch Neurol       Date:  2006-09

3.  Prevalence of diabetes, impaired fasting glucose, and impaired glucose tolerance in U.S. adults. The Third National Health and Nutrition Examination Survey, 1988-1994.

Authors:  M I Harris; K M Flegal; C C Cowie; M S Eberhardt; D E Goldstein; R R Little; H M Wiedmeyer; D D Byrd-Holt
Journal:  Diabetes Care       Date:  1998-04       Impact factor: 19.112

4.  Obesity and vascular risk factors at midlife and the risk of dementia and Alzheimer disease.

Authors:  Miia Kivipelto; Tiia Ngandu; Laura Fratiglioni; Matti Viitanen; Ingemar Kåreholt; Bengt Winblad; Eeva-Liisa Helkala; Jaakko Tuomilehto; Hilkka Soininen; Aulikki Nissinen
Journal:  Arch Neurol       Date:  2005-10

5.  Obesity in middle age and future risk of dementia: a 27 year longitudinal population based study.

Authors:  Rachel A Whitmer; Erica P Gunderson; Elizabeth Barrett-Connor; Charles P Quesenberry; Kristine Yaffe
Journal:  BMJ       Date:  2005-04-29

Review 6.  IANA (International Academy on Nutrition and Aging) Expert Group: weight loss and Alzheimer's disease.

Authors:  S Gillette Guyonnet; G Abellan Van Kan; E Alix; S Andrieu; J Belmin; G Berrut; M Bonnefoy; P Brocker; T Constans; M Ferry; A Ghisolfi-Marque; L Girard; R Gonthier; O Guerin; M-P Hervy; P Jouanny; M-C Laurain; L Lechowski; F Nourhashemi; A Raynaud-Simon; P Ritz; J Roche; Y Rolland; T Salva; B Vellas
Journal:  J Nutr Health Aging       Date:  2007 Jan-Feb       Impact factor: 4.075

Review 7.  Survival advantages of obesity in dialysis patients.

Authors:  Kamyar Kalantar-Zadeh; Kevin C Abbott; Abdulla K Salahudeen; Ryan D Kilpatrick; Tamara B Horwich
Journal:  Am J Clin Nutr       Date:  2005-03       Impact factor: 7.045

8.  An 18-year follow-up of overweight and risk of Alzheimer disease.

Authors:  Deborah Gustafson; Elisabet Rothenberg; Kaj Blennow; Bertil Steen; Ingmar Skoog
Journal:  Arch Intern Med       Date:  2003-07-14

9.  Incidence and prevalence of dementia in the Cardiovascular Health Study.

Authors:  Annette L Fitzpatrick; Lewis H Kuller; Diane G Ives; Oscar L Lopez; William Jagust; John C S Breitner; Beverly Jones; Constantine Lyketsos; Corinne Dulberg
Journal:  J Am Geriatr Soc       Date:  2004-02       Impact factor: 5.562

10.  Evaluation of dementia in the cardiovascular health cognition study.

Authors:  Oscar L Lopez; Lewis H Kuller; Annette Fitzpatrick; Diane Ives; James T Becker; Norman Beauchamp
Journal:  Neuroepidemiology       Date:  2003 Jan-Feb       Impact factor: 3.282

View more
  276 in total

Review 1.  Obesity, leptin, and Alzheimer's disease.

Authors:  Edward B Lee
Journal:  Ann N Y Acad Sci       Date:  2011-12       Impact factor: 5.691

2.  Body mass index correlates negatively with white matter integrity in the fornix and corpus callosum: a diffusion tensor imaging study.

Authors:  Jiansong Xu; Yang Li; Haiqun Lin; Rajita Sinha; Marc N Potenza
Journal:  Hum Brain Mapp       Date:  2011-12-03       Impact factor: 5.038

Review 3.  Perimenopause and cognition.

Authors:  Gail A Greendale; Carol A Derby; Pauline M Maki
Journal:  Obstet Gynecol Clin North Am       Date:  2011-09       Impact factor: 2.844

4.  Weight loss and incident dementia in elderly Yoruba Nigerians: a 10-year follow-up study.

Authors:  Adesola Ogunniyi; Su Gao; Frederick W Unverzagt; Olusegun Baiyewu; Oyewusi Gureje; James Tat Nguyen; Valerie Smith-Gamble; Jill R Murrell; Ann M Hake; Kathleen S Hall; Hugh C Hendrie
Journal:  Int Psychogeriatr       Date:  2010-08-25       Impact factor: 3.878

Review 5.  Can bariatric surgery reduce risk of Alzheimer's disease?

Authors:  Kelly M Stanek; John Gunstad
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2012-07-04       Impact factor: 5.067

6.  Comparisons of plasma/serum micronutrients between Okinawan and Oregonian elders: a pilot study.

Authors:  Hiroko H Dodge; Yuriko Katsumata; Hidemi Todoriki; Shoutoku Yasura; D Craig Willcox; Gene L Bowman; Bradley Willcox; Scott Leonard; Aaron Clemons; Barry S Oken; Jeffrey A Kaye; Maret G Traber
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2010-07-19       Impact factor: 6.053

7.  A Cross-Sectional Analysis of Late-Life Cardiovascular Factors and Their Relation to Clinically Defined Neurodegenerative Diseases.

Authors:  Brittany N Dugger; Michael Malek-Ahmadi; Sarah E Monsell; Walter A Kukull; Bryan K Woodruff; Eric M Reiman; Thomas G Beach; Jeffrey Wilson
Journal:  Alzheimer Dis Assoc Disord       Date:  2016 Jul-Sep       Impact factor: 2.703

Review 8.  Nutrition and neurodegeneration: epidemiological evidence and challenges for future research.

Authors:  Sophie Gillette-Guyonnet; Marion Secher; Bruno Vellas
Journal:  Br J Clin Pharmacol       Date:  2013-03       Impact factor: 4.335

9.  Mineralocorticoid receptor antagonism prevents obesity-induced cerebral artery remodeling and reduces white matter injury in rats.

Authors:  Paulo W Pires; Jonathon L McClain; Sebastian F Hayoz; Anne M Dorrance
Journal:  Microcirculation       Date:  2018-06-07       Impact factor: 2.628

10.  Amyloid-beta burden predicts prospective decline in body mass index in clinically normal adults.

Authors:  Jennifer S Rabin; Zahra Shirzadi; Walter Swardfager; Bradley J MacIntosh; Aaron Schultz; Hyun-Sik Yang; Rachel F Buckley; Jennifer R Gatchel; Dylan Kirn; Jeremy J Pruzin; Trey Hedden; Nir Lipsman; Dorene M Rentz; Sandra E Black; Keith A Johnson; Reisa A Sperling; Jasmeer P Chhatwal
Journal:  Neurobiol Aging       Date:  2020-03-07       Impact factor: 4.673

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.